Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
Top Cited Papers
Open Access
- 1 June 2011
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 19 (6), 1058-1069
- https://doi.org/10.1038/mt.2011.72
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Engineering Liver-detargeted AAV9 Vectors for Cardiac and Musculoskeletal Gene TransferMolecular Therapy, 2011
- BALB/c Mice Show Impaired Hepatic Tolerogenic Response Following AAV Gene Transfer to the LiverMolecular Therapy, 2010
- Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood–Brain Barrier (BBB)Molecular Therapy, 2010
- RETRACTED ARTICLE: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMNNature Biotechnology, 2010
- Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscleNature Biotechnology, 2010
- The Pleiotropic Effects of Natural AAV Infections on Liver-directed Gene Transfer in MacaquesMolecular Therapy, 2010
- Distinct immune responses to transgene products from rAAV1 and rAAV8 vectorsProceedings of the National Academy of Sciences of the United States of America, 2009
- Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor NeuronsMolecular Therapy, 2009
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytesNature Biotechnology, 2008
- Expanded Repertoire of AAV Vector Serotypes Mediate Unique Patterns of Transduction in Mouse BrainMolecular Therapy, 2008